Metformin partially reverses the inhibitory effect of co-culture with ER.sup.-/PR.sup.-/HER2.sup.+ breast cancer cells on biomarkers of monocyte antitumor activity

• Published in: PloS one 2020-10, Vol.15 (10), p.e0240982
• Main Authors: Dahmani, Zoheir, Addou-Klouche, Lynda, Gizard, Florence, Dahou, Sara, Messaoud, Aida, Chahinez Djebri, Nihel, Benaissti, Mahmoud Idris, Mostefaoui, Meriem, Terbeche, Hadjer, Nouari, Wafa, Miliani, Marwa, Lefranc, Gérard, Fernandez, Anne, Lamb, Ned J, Aribi, Mourad
• Format: Article
• Language: English
• Subjects: Breast cancer; Cancer cells; Control; Development and progression; Drug therapy; Growth; Metformin; Patient outcomes
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0240982

Immune activities of monocytes (MOs) can be altered within the microenvironment of solid malignancies, including breast cancer. Metformin (1,1-dimethylbiguanide hydrochloride, MET), has been shown to decrease tumor cell proliferation, but its effects have yet to be explored with respect to MOs (monocytes) activity during their crosstalk with breast cancer cells. Here, we investigated the effects of MET on overall phenotypic functional activities, including cellular immunometabolism and protective redox signaling based-biomarkers, intracellular free calcium ions (.sub.if Ca.sup.2+ ), phagocytosis and co-operative cytokines (IFN-[gamma] and IL-10) of autologous MOs before and during their interplay with primary ER.sup.- /PR.sup.- /HER2.sup.+ breast cancer cells. Human primary breast cancer cells were either cultured alone or co-cultured with autologous MOs before treatment with MET. MET downregulated breast cancer cell proliferation and phagocytosis, while having no significant effect on the ratio of phosphorylated Akt (p-Akt) to total Akt. Additionally, we observed that, in the absence of MET treatment, the levels of lactate dehydrogenase (LDH)-based cytotoxicity, catalase, .sub.if Ca.sup.2+, IL-10 and arginase activity were significantly reduced in co-cultures compared to levels in MOs cultured alone whereas levels of inducible nitric oxide synthase (iNOS) activity were significantly increased. In contrast, MET treatment reduced the effects measured in co-culture on the levels of LDH-based cytotoxicity, arginase activity, catalase, .sub.if Ca.sup.2+, and IFN-[gamma]. MET also induced upregulation of both iNOS and arginase in MO cells, although the increase did not reach significant difference for iNOS activity. Moreover, MET induced a robust increase of superoxide dismutase (SOD) activity in MOs, but not in MOs co-cultured with breast cancer cells. Furthermore, MET markedly upregulated the levels of IFN-[gamma] production and downregulated those of IL-10 in isolated MOs, while inducing a slight opposing up-regulation of IL-10 production in co-cultures. Our results show that the biomarkers of phenotypic functional activities of MOs are modified after co-culturing with primary human breast cancer cells. Treatment of co-cultures with MET resulted in increased release of antitumor cytokine IFN-[gamma] and .sub.if Ca.sup.2+, and increased cell necrosis during breast cancer cells-MOs crosstalk.